About Akso Health Group
https://www.xiaobaimaimai.comAkso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, etc. It also offers consultancy and information technology support services; and trades in branded products, as well as promotes products.
CEO
Yilin Wang
Compensation Summary
(Year )
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2020-08-24 | Reverse | 1:3 |
Ratings Snapshot
Rating : B-
Price Target
Institutional Ownership
RENAISSANCE TECHNOLOGIES LLC
Shares:129.2K
Value:$182.82K
GEODE CAPITAL MANAGEMENT, LLC
Shares:14.97K
Value:$21.19K
UBS GROUP AG
Shares:13.03K
Value:$18.44K
Summary
Showing Top 3 of 5
About Akso Health Group
https://www.xiaobaimaimai.comAkso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, etc. It also offers consultancy and information technology support services; and trades in branded products, as well as promotes products.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $3.92M | $82.64M | $-67.2M | -1.71K% | $-0.2 | $-624.7K |
| Q3-2025 | $3.92M ▲ | $82.64M ▲ | $-67.2M ▼ | -1.71K% ▼ | $-0.2 ▼ | $-624.7K ▼ |
| Q2-2025 | $3.47M | $366.73K | $-293.32K | -8.46% | $-0 | $-261.89K |
| Q1-2025 | $3.47M ▲ | $366.73K ▼ | $-293.32K ▲ | -8.46% ▲ | $-0 ▲ | $-261.89K ▼ |
| Q4-2024 | $760.38K | $3.2M | $-3M | -394.62% | $-0.14 | $0 |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $176.23M | $214.95M | $15.8M | $199.12M |
| Q3-2025 | $176.23M ▲ | $214.95M ▲ | $15.8M ▲ | $199.12M ▼ |
| Q2-2025 | $91.37M | $212.95M | $12.3M | $200.56M |
| Q1-2025 | $91.37M ▲ | $212.95M ▲ | $12.3M ▲ | $200.56M ▲ |
| Q4-2024 | $85.17M | $142.02M | $3.59M | $138.37M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $-67.2M | $3.01M | $-24.77M | $64.34M | $0 | $3M |
| Q3-2025 | $-67.2M ▼ | $3.01M ▲ | $-24.77M ▲ | $64.34M ▲ | $0 | $3M ▲ |
| Q2-2025 | $-293.32K | $-2.42M | $-28.19M | $33.61M | $0 | $-2.49M |
| Q1-2025 | $-293.32K ▲ | $-2.42M ▼ | $-28.19M ▼ | $33.61M ▼ | $0 ▼ | $-2.49M ▼ |
| Q4-2024 | $-3M | $554.45K | $-28.13M | $65.65M | $75.96M | $554.45K |
Revenue by Products
| Product | Q1-2014 | Q2-2014 | Q3-2021 | Q2-2023 |
|---|---|---|---|---|
 Interest income | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 Commission Services | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 Interest | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 Home Infusion Therapy | $330.00M ▲ | $330.00M ▲ | $0 ▼ | $0 ▲ |
 Home Respiratory Therapy And Home Medical Equipment | $290.00M ▲ | $280.00M ▼ | $0 ▼ | $0 ▲ |
CEO
Yilin Wang
Compensation Summary
(Year )
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2020-08-24 | Reverse | 1:3 |
Ratings Snapshot
Rating : B-
Price Target
Institutional Ownership
RENAISSANCE TECHNOLOGIES LLC
Shares:129.2K
Value:$182.82K
GEODE CAPITAL MANAGEMENT, LLC
Shares:14.97K
Value:$21.19K
UBS GROUP AG
Shares:13.03K
Value:$18.44K
Summary
Showing Top 3 of 5